Delivery Order SPM2DP13D0006-1867
Award Date
10/9/14
Potential Completion Date
7/25/22
Potential Value
$2K
Federal Agency
Medical Supply Chain
Awardee
Medimmune Biologics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to MedImmune Biologics, Inc. for the provision of influenza virus vaccines. The contract has a total ceiling value of $95,527.50 and an ultimate completion date of December 21, 2015. The contract was not set aside for any specific business type. MedImmune Biologics, Inc. is the prime contractor for this award, which is part of the Medical Supply Chain program within the Department of Defense.</p>
This is a firm fixed price delivery order contract awarded by the Defense Department's Medical Supply Chain to MedImmune Biologics, Inc. for the purchase of influenza virus vaccine. The contract has a ceiling value of $98,102.00 and an ultimate completion date of December 21, 2015. The contract does not have a set-aside designation. As a delivery order contract, this award is part of a larger contract vehicle, but no further details about the vehicle are provided. The prime contractor for this...
<p>This is a federal contract award from the Defense agency Medical Supply Chain to Medimmune Biologics, Inc. for influenza virus vaccines. The contract has a ceiling value of $170,730.00 and was awarded on November 19, 2015 with a completion date of December 21, 2015. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. As the prime contractor, Medimmune Biologics, Inc. will be responsible for delivering the requested influenza virus vaccines to the government.</p>
This federal contract award, with ID SPE2DP15D0003|1199, was issued by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. The $95,527.50 firm-fixed-price delivery order is for the provision of influenza virus vaccines. The contract has an ultimate completion date of December 21, 2015. There is no set-aside designation for this award. Medimmune Biologics, Inc. is a for-profit organization, and this award indicates they have received other federal contract and grant awards. The DLA,...
This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC on September 12, 2013. The contract has a ceiling value of $5,625,000.00 and a period of performance through August 31, 2015. It was awarded under the Pandemic Influenza Preparedness and Response 2012-2016 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. As a...
This is a $4,588,128.50 firm-fixed-price delivery order contract awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of influenza virus vaccines and does not have a set-aside designation. Seqirus USA Inc. is a significant federal contractor, holding several large Indefinite Delivery Contracts (IDCs) with agencies like the Department of Veterans Affairs and Centers for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of 8502637428 influenza virus vaccine. The $100,660.00 contract has a performance period ending on November 30, 2015 and was not set aside for any socioeconomic category. Glaxosmithkline holds multiple federal contract vehicles with agencies like the Department of Veterans Affairs, Centers for Disease Control and Prevention, and DLA to...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a ceiling value of $259,000.00 and a period of performance ending on November 30, 2015. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. This contract supports annual flu...
This federal contract award, identified as SPE2DP16D0005|0001, is for the delivery of influenza virus vaccines. The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The contract is a firm-fixed-price delivery order with a ceiling value of $10,003,042.50 and a performance period ending on September 30, 2016. The contract was awarded by the...
This is a $94,800.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the supply of influenza virus vaccines. The contract has no set-aside designation. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and...